Other Species / Isoforms
  EME1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6-p
__MALKKssPsLDsG
0 1
EME1 (human) __MALKKssPsLDsG S6-p
EME1 (mouse) __MALRRLSLSRLst L6
S7-p
_MALKKssPsLDsGD
0 2
EME1 (human) _MALKKssPsLDsGD S7-p
EME1 (mouse) _MALRRLSLSRLstE S7
S9-p
ALKKssPsLDsGDsD
0 1
EME1 (human) ALKKssPsLDsGDsD S9-p
EME1 (mouse) ALRRLSLSRLstEsD S9
S12-p
KssPsLDsGDsDsEE
Upstream
0 11
Treatment
  • MLN8054
EME1 (human) KssPsLDsGDsDsEE S12-p
EME1 (mouse) RLSLSRLstEsDSED S12-p
G13
ssPsLDsGDsDsEEL
0 1
EME1 (human) ssPsLDsGDsDsEEL G13
EME1 (mouse) LSLSRLstEsDSEDL T13-p
S15-p
PsLDsGDsDsEELPT
0 11
EME1 (human) PsLDsGDsDsEELPT S15-p
EME1 (mouse) LSRLstEsDSEDLPT S15-p
S17-p
LDsGDsDsEELPTFA
0 1
EME1 (human) LDsGDsDsEELPTFA S17-p
EME1 (mouse) RLstEsDSEDLPTFA S17
T33-p
LKKEPSStKRRQPER
0 1
EME1 (human) LKKEPSStKRRQPER T33-p
EME1 (mouse) LKKEPSSTNRKPPQR T33
S64-p
PPAPELFsPPVPEIA
0 1
EME1 (human) PPAPELFsPPVPEIA S64-p
EME1 (mouse) PPSPGLKGPPCVPSA G63
S84-p
TQPVRLLssEsEDEE
0 15
EME1 (human) TQPVRLLssEsEDEE S84-p
EME1 (mouse) AGPVRVLssssEDED S84-p
S85-p
QPVRLLssEsEDEEE
0 17
EME1 (human) QPVRLLssEsEDEEE S85-p
EME1 (mouse) GPVRVLssssEDEDV S85-p
E86
PVRLLssEsEDEEEF
0 1
EME1 (human) PVRLLssEsEDEEEF E86
EME1 (mouse) PVRVLssssEDEDVF S86-p
S87-p
VRLLssEsEDEEEFI
Upstream
0 20
Treatment
  • dasatinib
EME1 (human) VRLLssEsEDEEEFI S87-p
EME1 (mouse) VRVLssssEDEDVFV S87-p
K103-sm
LAQRLTCkFLTHKQL
0 1
EME1 (human) LAQRLTCkFLTHKQL K103-sm
EME1 (mouse) LAERITCKLLTSKQL K103
S111-p
FLTHKQLsPEDSSsP
Upstream
0 15
Treatment
  • nocodazole
  • ZK-Thiazolidinone
EME1 (human) FLTHKQLsPEDSSsP S111-p
EME1 (mouse) LLTSKQLCPELSSSS C111
S117-p
LsPEDSSsPVKSVLD
Upstream
0 5
Treatment
  • nocodazole
EME1 (human) LsPEDSSsPVKSVLD S117-p
EME1 (mouse) LCPELSSSSLKTGLD S117
S132-p
HQNNEGAsCDWkKPF
0 1
EME1 (human) HQNNEGAsCDWkKPF S132-p
EME1 (mouse) GQNNASAPCDWKRQP P132
K136-sm
EGAsCDWkKPFPKIP
0 1
EME1 (human) EGAsCDWkKPFPKIP K136-sm
EME1 (mouse) ASAPCDWKRQPWPKI K136
T150-p
PEVPLHDtPERSAAD
Upstream
0 17
Treatment
  • nocodazole
EME1 (human) PEVPLHDtPERSAAD T150-p
EME1 (mouse) PDVPLHGALEKSAAN A151
K232-sm
TLRRQERkNAALVtR
0 1
EME1 (human) TLRRQERkNAALVtR K232-sm
EME1 (mouse) PRQHERKKKAEMIKR K231
K232-ub
TLRRQERkNAALVtR
0 1
EME1 (human) TLRRQERkNAALVtR K232-ub
EME1 (mouse) under review -
T238-p
RkNAALVtRMkAQRP
0 1
EME1 (human) RkNAALVtRMkAQRP T238-p
EME1 (mouse) KKKAEMIKRLKAQRP K237
K241-ub
AALVtRMkAQRPEEC
0 1
EME1 (human) AALVtRMkAQRPEEC K241-ub
EME1 (mouse) AEMIKRLKAQRPEEC K240
K329-ub
VSMIDNGkQGsLDSt
0 1
EME1 (human) VSMIDNGkQGsLDSt K329-ub
EME1 (mouse) MSMAYNLKQASPSST K329
S332-p
IDNGkQGsLDStMkG
0 1
EME1 (human) IDNGkQGsLDStMkG S332-p
EME1 (mouse) AYNLKQASPSSTEKG S332
T336-p
kQGsLDStMkGkETL
0 1
EME1 (human) kQGsLDStMkGkETL T336-p
EME1 (mouse) KQASPSSTEKGKETL T336
K338-m2
GsLDStMkGkETLQG
0 1
EME1 (human) GsLDStMkGkETLQG K338-m2
EME1 (mouse) ASPSSTEKGKETLRS K338
K338-sm
GsLDStMkGkETLQG
0 1
EME1 (human) GsLDStMkGkETLQG K338-sm
EME1 (mouse) ASPSSTEKGKETLRS K338
K340-m2
LDStMkGkETLQGFV
0 1
EME1 (human) LDStMkGkETLQGFV K340-m2
EME1 (mouse) PSSTEKGKETLRSFV K340
K340-ub
LDStMkGkETLQGFV
0 4
EME1 (human) LDStMkGkETLQGFV K340-ub
EME1 (mouse) PSSTEKGKETLRSFV K340
K353-ub
FVTDITAkTAGkALS
0 1
EME1 (human) FVTDITAkTAGkALS K353-ub
EME1 (mouse) under review -
K357-ub
ITAkTAGkALSLVIV
0 2
EME1 (human) ITAkTAGkALSLVIV K357-ub
EME1 (mouse) DVTAKTGKALSLVIV K356
K441-ub
DFTCAFTkAVAEAPF
0 1
EME1 (human) DFTCAFTkAVAEAPF K441-ub
EME1 (mouse) DFTCAFTKAVAEAPF K441
K449-ub
AVAEAPFkKLRDETT
0 6
EME1 (human) AVAEAPFkKLRDETT K449-ub
EME1 (mouse) AVAEAPFKKLRDQVT K449